Group 1 - The core viewpoint of the articles highlights the shift in pharmaceutical production dominance from Germany to Asian countries, particularly China and India, with significant implications for the global pharmaceutical supply chain [1][2] Group 2 - A study commissioned by Pro Generika reveals that 68% of key active pharmaceutical ingredients in the European market are sourced from Asia, with China supplying 24% and India 37% [1] - In the antibiotic sector, 47% of global production bases are located in China, while India accounts for 27%, and Europe only 23% [1] - The chairman of the German Pharmacists Association expressed concern over Germany's reliance on China for critical drug supplies, indicating a "huge dependency" [1] Group 3 - The European Union is facing a drug shortage crisis, with approximately 540 drugs listed as in short supply by the German Federal Institute for Drugs and Medical Devices [2] - A report from the European Court of Auditors points to the "fragile" nature of the EU's pharmaceutical supply chain and the "fragmented" internal market as root causes of the drug shortages [2] - The European Commission has announced plans to reduce dependency on countries like China and India for pharmaceuticals, but officials warn that this task is challenging due to cost pressures [2]